Staging of recurrent and advanced lung cancer with f-fdg pet in a coincidence technique (hybrid pet)

Nuclear Medicine Communications

Volumn 24, Issue 1, 2003, Pages 37-45

  Schmid, R A ^a   Hautmann, H ^a   Poellinger, B ^a   Kellner, W ^a   Moisseev, A ^a   Brinkbaeumer, K ^a   Weiss, M ^a   Hahn, K ^a   Dresel, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coincidence imaging; F FDG; Hybrid PET; Lung cancer

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BONE TUMOR; CANCER STAGING; CARCINOMA; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; INSTRUMENTATION; LARGE CELL CARCINOMA; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PLEURA TUMOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURAL NEOPLASMS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1842833912     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200301000-00013     Document Type: Article

References (39)

1. Becker N, Muscat JE, Wynder EL. Cancer mortality in the United States and Germany. J Cancer Res Clin Oncol 2001; 127: 293-300.
2. Leonard CT, Whyte RI, Lillington GA. Primary non-small-cell lung cancer: determining the suitability of the patient and tumor for resection. Curr Opin Pulm Med 2000; 6: 391-395.
3. Park BJ, Louie O, Altorki N. Staging and the surgical management of lung cancer. Radiol Clin North Am 2000; 38: 545-561.
4. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991; 67: 1544-1550.
5. Som P, Atkins HL, Bandoypadhyay DE, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21: 670-675.
6. Al-Sugair A, Coleman RE. Applications of PET in lung cancer. Semin Nucl Med 1998; 28: 303-319.
7. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM. Metaanalysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose. Pneumologie 2001; 55: 367-377 (in German).
8. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-809.
9. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
10. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-2149.
11. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
12. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. Radiology 1994; 191: 461-465.
13. 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med 2001; 28: 763-778.
14. 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med 1999; 40: 574-578.
15. Tatsumi M, Yutani K, Watanabe Y, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 1999; 40: 566-573.
16. Roman MR, Rossleigh MA, Angelides S, Walker BM, Dixon J. Staging and managing lung tumors using F-18 FDG coincidence detection. Clin Nucl Med 2001; 26: 383-388.
17. Weber WA, Neverve J, Sklarek J, et al. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system. Eur J Nucl Med 1999; 26: 388-395.
18. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
19. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000; 18: 106-115.
20. Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001; 28: 483-488.
21. Scott WJ, Shepherd J, Gambhir SS. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 1998; 66: 1876-1885.
22. Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000; 6: 3837-3844.
23. Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999; 14: 1376-1380.
24. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343: 254-261.
25. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 1997; 52: 438-441.
26. MacManus MP, Hicks RJ, Matthews JP. High rate of detection of unsuspected distant metastases by PET in apparent Stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 287-293.
27. Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 2000; 27: 1598-1609.
28. Lottes G, Schober O. Costs of F-18-FDG PET with a satellite concept: update. Nuklearmedizin 2000; 39: 72-76 (in German).
29. Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun 1993; 14: 955-961.
30. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36: 988-995.
31. Macfarlane DJ, Cotton L, Ackermann RJ, et al. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425-429.
32. Lewellen TK, Miyaoka RS, Swan WL. PET imaging using dual-headed gamma cameras: an update. Nucl Med Commun 1999; 20: 5-12.
33. Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun 1996; 17: 758-766.
34. Dresel S, Schwenzer K, Brinkbaumer K, Schmid R, Szeimies U, Popperl G, Hahn K. [F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT. Nuklearmedizin 2001; 40: 172-178 (in German).
35. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med 1996; 23: 741-747.
36. Stokkel MP, Bakker PF, Heine R, Schlosser NJ, Lammers JW, Van Rijk PP. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer. Nucl Med Commun 1999; 20: 1001-1007.
37. Delbeke D, Patton JA, Martin WH, Sandler MP. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J Nucl Med 1999; 40: 110-117.
38. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. Am J Roentgenol 2000; 175: 245-249.
39. m-MDP bone scintigraphy. Nucl Med Commun 2001; 22: 875-879.